Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Payables (2018 - 2025)

Exagen (XGN) has disclosed Payables for 8 consecutive years, with $4.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Payables changed 0.39% year-over-year to $4.2 million, compared with a TTM value of $4.2 million through Dec 2025, changed 0.39%, and an annual FY2025 reading of $4.2 million, changed 0.39% over the prior year.
  • Payables was $4.2 million for Q4 2025 at Exagen, up from $3.6 million in the prior quarter.
  • Across five years, Payables topped out at $4.5 million in Q1 2025 and bottomed at $1.1 million in Q3 2024.
  • Average Payables over 5 years is $2.7 million, with a median of $2.5 million recorded in 2021.
  • The sharpest move saw Payables crashed 57.84% in 2023, then surged 222.08% in 2025.
  • Year by year, Payables stood at $2.5 million in 2021, then rose by 22.23% to $3.0 million in 2022, then grew by 2.79% to $3.1 million in 2023, then surged by 32.13% to $4.1 million in 2024, then increased by 0.39% to $4.2 million in 2025.
  • Business Quant data shows Payables for XGN at $4.2 million in Q4 2025, $3.6 million in Q3 2025, and $2.5 million in Q2 2025.